More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$58.68B
EPS
3.31
P/E ratio
55.5
Price to sales
2.4
Dividend yield
1.968%
Beta
0.237374
Previous close
$216.47
Today's open
$215.04
Day's range
$214.05 - $216.98
52 week range
$140.11 - $220.36
show more
CEO
Thomas E. Polen
Employees
72000
Headquarters
Franklin Lakes, NJ
Exchange
New York Stock Exchange
Shares outstanding
272386800
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Nike Among 13 Dividend Growth Companies To Announce Annual Dividend Increases In Latter Half Of November
I expect Nike (NKE) to raise its dividend 1.2–2.4%, as weak sales, flat EPS and a payout ratio around 80% constrain growth. Matthews International (MATW) risks a dividend cut; Hormel (HRL) faces an above-100% payout ratio and likely will increase its annual dividend just one cent. Motorola Solutions (MSI) should deliver a 10%+ increase, while Marzetti (MZTI) is poised to extend its 63-year streak with a roughly 5% boost.
Seeking Alpha • Nov 16, 2026

Brown Advisory Large-Cap Sustainable Value Strategy Q3 2026 Portfolio Review
Tenet Healthcare reported a strong second quarter in the face of investor concerns about slowing end market demand and low starting valuation, with revenue and EBITDA guide increased 1% and 6%, respectively. After appreciating more than 100% during the second quarter, Applied Materials corrected somewhat during the third quarter. We established a new position in Microsoft in early July. We have spent a considerable amount of time combing through the software space over the last few months given the sell-off in the sector.
Seeking Alpha • Nov 13, 2026

BD to Host Investor Day on December 10, 2026
FRANKLIN LAKES, N.J., Nov. 10, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host an Investor Day for institutional investors and financial analysts on Thursday, December 10, 2026, in New York, NY.
PRNewsWire • Nov 10, 2026

Dividend Announcements: October 31-November 6, 2026 (Part 1 Of 2)
I monitor dividend announcements across 1,200+ stocks, focusing on dividend growth streaks, safety, and valuation to identify conviction opportunities. In this first of two articles, I summarize last week's dividend announcements from Dividend Champions and companies with dividend growth streaks under 10 years. EOG Resources stands out with the highest Quality Score (7.83), trading 11.39% below fair value, but its 7.84% dividend hike trails projected growth.
Seeking Alpha • Nov 9, 2026

3 Medical Device Stocks That Keep Raising Dividends. One Just Hit 55 Years
Hospitals reorder syringes, sensors, and implants whether the economy booms or stalls, and three device makers turn that habit into payouts that grow every year.
24/7 Wall Street • Nov 7, 2026

Becton, Dickinson and Company Q4 Earnings Call Highlights
Becton, Dickinson and Company NYSE: BDX reported higher fiscal fourth-quarter revenue and adjusted earnings as demand for patient monitoring, biologic drug delivery and other products helped offset a difficult comparison for its Alaris infusion platform.
MarketBeat • Nov 6, 2026

3 Stocks in Focus That Hiked Dividends Amid Ongoing Market Volatility
BDX, COR and UNF recently hiked dividends, offering investors steady income opportunities as market volatility, inflation and economic uncertainty persist.
Zacks Investment Research • Nov 6, 2026

Becton, Dickinson and Company (BDX) Q4 2026 Earnings Call Transcript
Becton, Dickinson and Company (BDX) Q4 2026 Earnings Call Transcript
Seeking Alpha • Nov 5, 2026

BD Board Increases Dividend for 55th Consecutive Year, Authorizes 10 Million Additional Share Repurchases
FRANKLIN LAKES, N.J., Nov. 5, 2026 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has declared a quarterly dividend of $1.06 per common share, an increase of 1.0% from the previous quarter.
PRNewsWire • Nov 5, 2026

BD Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Q4 revenue of $5.3 billion increased 5.4% as reported, 5.6% FXN Q4 GAAP and adjusted diluted EPS of $2.52 and $4.15, respectively FY26 revenue of $19.5 billion increased 4.9% as reported, 3.9% FXN FY26 GAAP and adjusted diluted EPS of $5.06 and $12.70, respectively FY26 cash from continuing operations increased 30.0% to $3.6 billion and free cash flow increased 42.5% to $2.9 billion Company issues FY27 guidance FRANKLIN LAKES, N.J., Nov. 5, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2026 fourth quarter and full year, which ended September 30, 2026.
PRNewsWire • Nov 5, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Becton Dickinson and Company commission-free¹. Build wealth for the long term using automated trading and transfers.